Project Navigator
Let's try to finance it!
A new, user friendly way, to get information about current clinical trials available to prostate cancer patients.
Tags
225Ac abiraterone abiraterone acetate ADC ADT AI ai in healthcare antibody-drug conjugate apalutamide ATM B7-H3 bispecific antibody bone metastases bone metastasis BRCA cancer immunotherapy CAR-T clinical trial clinical trials crispr darolutamide docetaxel drug repurposing drug resistance enzalutamide HRR immune checkpoint inhibitors immunotherapy mcrpc metastatic castration-resistant prostate cancer metastatic hormone-sensitive prostate cancer mHSPC mRNA NEPC neuroendocrine prostate cancer olaparib oncolytic virus Pluvicto prostate cancer protac PSMA radioligand therapy radiopharmaceuticals real-world data theranostics
Latest Posts
- News pre|CISION Platform: Delivering Two Complementary Therapies from One Molecule October 27, 2025
- Helicon Degraders Show a New Path in Prostate Cancer Therapy October 27, 2025
- UPDATE 2: HLD-0915 Shows Promising Early Results in Drug-Resistant Prostate Cancer October 27, 2025
- Newsletter 43/2025 October 26, 2025
Phase 2 Trial Compares Cabazitaxel and ARPIs in Poor-Prognosis mCRPC After Docetaxel
/in Clinical Trial, Metastatic, Phase 2/by MaxLUNAR Trial Shows Combination Therapy Doubles Progression-Free Survival in Recurrent Prostate Cancer
/in Clinical Trial, Metastatic, Phase 2/by MaxASPIRE Trial Explores Early Chemotherapy Addition for Advanced Prostate Cancer
/in Clinical Trial, Metastatic, Phase 3/by MaxPhase 1 Trial: 161Tb-PSMA Offers Hope After Lutetium Failure in mCRPC
/in Clinical Trial, Metastatic/by MaxOptimized Epigenetic Regulators for Durable Gene Silencing (PCSK9)
/in Preclinical Research/by MaxEfficacy and Safety of Combination ARSI, Denosumab, and Local Radiotherapy in Poly-Metastatic Prostate Cancer
/in Clinical Trial, Metastatic, Phase 2/by MaxDOLPHIN AI Uncovers Hundreds of Invisible Cancer Markers
/in Artificial Intelligence/by MaxBlocking Ant2 Supercharges the Immune System Against Cancer
/in Immunotherapy, Preclinical Research/by Max